JPH045436B2 - - Google Patents
Info
- Publication number
- JPH045436B2 JPH045436B2 JP63103851A JP10385188A JPH045436B2 JP H045436 B2 JPH045436 B2 JP H045436B2 JP 63103851 A JP63103851 A JP 63103851A JP 10385188 A JP10385188 A JP 10385188A JP H045436 B2 JPH045436 B2 JP H045436B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- optically active
- ethyl
- hydroxybutanoate
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 11
- -1 ketone compound Chemical class 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 241000186321 Cellulomonas Species 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 description 28
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 17
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 17
- ZAJNMXDBJKCCAT-YFKPBYRVSA-N ethyl (3s)-4-chloro-3-hydroxybutanoate Chemical class CCOC(=O)C[C@H](O)CCl ZAJNMXDBJKCCAT-YFKPBYRVSA-N 0.000 description 11
- 101710172561 3alpha-hydroxysteroid dehydrogenase Proteins 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 7
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 7
- 238000004811 liquid chromatography Methods 0.000 description 7
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 7
- WVYWICLMDOOCFB-UHFFFAOYSA-N 4-methyl-2-pentanol Chemical compound CC(C)CC(C)O WVYWICLMDOOCFB-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- 108091006162 SLC17A6 Proteins 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 102000046053 Vesicular Glutamate Transport Protein 2 Human genes 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 2-octanone Chemical compound CCCCCCC(C)=O ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 0.000 description 4
- 102100024089 Aldo-keto reductase family 1 member C2 Human genes 0.000 description 4
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 4
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 4
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WVYWICLMDOOCFB-LURJTMIESA-N (2s)-4-methylpentan-2-ol Chemical compound CC(C)C[C@H](C)O WVYWICLMDOOCFB-LURJTMIESA-N 0.000 description 3
- 229920002271 DEAE-Sepharose Polymers 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- ZAJNMXDBJKCCAT-RXMQYKEDSA-N ethyl (3r)-4-chloro-3-hydroxybutanoate Chemical compound CCOC(=O)C[C@@H](O)CCl ZAJNMXDBJKCCAT-RXMQYKEDSA-N 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000011942 biocatalyst Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- WVYWICLMDOOCFB-ZCFIWIBFSA-N (2r)-4-methylpentan-2-ol Chemical compound CC(C)C[C@@H](C)O WVYWICLMDOOCFB-ZCFIWIBFSA-N 0.000 description 1
- PHIQHXFUZVPYII-LURJTMIESA-N (S)-carnitine Chemical compound C[N+](C)(C)C[C@@H](O)CC([O-])=O PHIQHXFUZVPYII-LURJTMIESA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RTZQCYRFUVPVQG-UHFFFAOYSA-N 1-isocyanato-2,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(N=C=O)=C1[N+]([O-])=O RTZQCYRFUVPVQG-UHFFFAOYSA-N 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 108010066477 Carnitine O-acetyltransferase Proteins 0.000 description 1
- 102100036357 Carnitine O-acetyltransferase Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- KWWOQRSLYPHAMK-YFKPBYRVSA-N ethyl (2s)-2-hydroxybutanoate Chemical compound CCOC(=O)[C@@H](O)CC KWWOQRSLYPHAMK-YFKPBYRVSA-N 0.000 description 1
- ZAJNMXDBJKCCAT-UHFFFAOYSA-N ethyl 4-chloro-3-hydroxybutanoate Chemical compound CCOC(=O)CC(O)CCl ZAJNMXDBJKCCAT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 102220127254 rs886044521 Human genes 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は3α−ヒドロキシステロイド脱水素酵
素を作用させることを特徴とする光学活性なアル
コールの新規な製造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a novel method for producing optically active alcohol, which is characterized by the action of 3α-hydroxysteroid dehydrogenase.
光学活性アルコールは医薬、農薬、生理活性物
質の合成中間体および強誘電性材料に用いられて
いる。たとえば4−クロロ−3(S)−ヒドロキシ
ブタン酸エチルの誘導体であるD−カルニチンは
カルニチンアセチルトランスフエラーゼを拮抗的
に阻害するような生理活性を有する。また光学活
性なR−(−)−2−オクタノールや2−メチル−
4(S)−ヒドロキシペンタンは強誘電性材料の素
材に用いることができる。
Optically active alcohols are used in medicines, agricultural chemicals, synthetic intermediates for physiologically active substances, and ferroelectric materials. For example, D-carnitine, which is a derivative of ethyl 4-chloro-3(S)-hydroxybutanoate, has physiological activity that competitively inhibits carnitine acetyltransferase. Also, optically active R-(-)-2-octanol and 2-methyl-
4(S)-hydroxypentane can be used as a raw material for ferroelectric materials.
従来、ケトン化合物を光学活性なアルコールに
変換する方法としては、化学触媒を用いる方法、
あるいは生体触媒を用いる方法が知られている。
化学触媒を用いる方法はNaBH4やLiAlH4を用い
て還元した場合、光学収率が非常に低くラセミ体
ができる。すなわちこのラセミ体を酒石酸やD−
マンデル酸のような光学分割剤を用いて光学分割
したのち、光学活性なアルコールを得るという繁
雑なステツプを踏まざるを得ない。また最近では
光学活性な配位子を持つたキラル触媒を用いて光
学活性なアルコールを得ようと試みられている
が、極低温で反応する必要のあることやキラル触
媒が高価でかつ再生が困難であることが問題とな
つている。 Conventionally, methods for converting ketone compounds into optically active alcohols include methods using chemical catalysts,
Alternatively, a method using a biocatalyst is known.
In methods using chemical catalysts, when reduced using NaBH 4 or LiAlH 4 , the optical yield is very low and a racemate is produced. In other words, this racemate is mixed with tartaric acid or D-
After optical resolution using an optical resolving agent such as mandelic acid, a complicated step must be taken to obtain an optically active alcohol. Recently, attempts have been made to obtain optically active alcohols using chiral catalysts with optically active ligands, but these efforts require reactions at extremely low temperatures, and chiral catalysts are expensive and difficult to regenerate. is becoming a problem.
一方、微生物、植物、動物などの生体触媒を用
いる方法は、一般に光学収率が高いという利点を
有する。たとえば4−クロロ−3(S)−ヒドロキ
シブタン酸エチルは「アニユアル・ニユーヨー
ク・アカデミツク・サイエンス434巻、186−193
(1984)」に記載されているように、種々の微生物
によつて発酵生産されることが明らかになつてい
る。 On the other hand, methods using biocatalysts such as microorganisms, plants, and animals generally have the advantage of high optical yield. For example, ethyl 4-chloro-3(S)-hydroxybutanoate is
(1984), it has become clear that the enzymes are fermented and produced by various microorganisms.
このように化学触媒を用いて光学活性なアルコ
ールを合成するのは、現在のところ技術的に困難
な問題が横たわつている。一方、微生物による発
酵生産の方法では原料あるいは生産物による菌体
の成育阻害が起こるため、原料を多く仕込めない
という問題点がある。また発酵液から生産物を採
取する際、副産物を除去しなければならないなど
精製に手間がかかるという問題点がある。
At present, there are technical difficulties in synthesizing optically active alcohols using chemical catalysts. On the other hand, the method of fermentation production using microorganisms has the problem that it is not possible to use a large amount of raw materials because the growth of bacterial cells is inhibited by the raw materials or products. Another problem is that it takes time and effort to purify the product, as by-products must be removed when the product is collected from the fermentation liquid.
本発明の目的は、このような問題点を解決し、
副産物が少く、効率よく光学活性アルコールを製
造する方法を提供することである。 The purpose of the present invention is to solve these problems,
An object of the present invention is to provide a method for efficiently producing an optically active alcohol with few by-products.
本発明者らは微生物由来の酵素を用いて、光学
活性なアルコールを製造する方法を鋭意検討した
結果、3α−ヒドロキシステロイド脱水素酵素を
用いれば効率よくケトン化合物を光学活性なアル
コールに変換することを見い出し、本発明を完成
した。
The present inventors have intensively investigated a method for producing optically active alcohol using enzymes derived from microorganisms, and have found that ketone compounds can be efficiently converted to optically active alcohol using 3α-hydroxysteroid dehydrogenase. They discovered this and completed the present invention.
即ち、本発明は、3α−ヒドロキシステロイド
脱水素酵素を用いて、一般式〔1〕
(式中、R1はメチル基又はハロゲン置換メチル
基を、R2は炭素数1〜5のアルキル基を示す)、
または、一般式〔2〕
(式中、nは1〜10の整数を示す)で示されるケ
トン化合物を光学活性アルコールに変換すること
を特徴とする光学活性アルコールの製造方法であ
る。 That is, the present invention uses 3α-hydroxysteroid dehydrogenase to synthesize the general formula [1] (In the formula, R 1 represents a methyl group or a halogen-substituted methyl group, and R 2 represents an alkyl group having 1 to 5 carbon atoms),
Or general formula [2] (wherein n represents an integer of 1 to 10) is a method for producing an optically active alcohol, which is characterized by converting a ketone compound represented by the formula into an optically active alcohol.
本発明に使用する3α−ヒドロキシステロイド
脱水素酵素(以後3α−HSDHと略す)は、セル
ロモナス・ツルバタKE31株〔微工研菌寄第9059
号〕由来のものが好ましい、これに限定されな
い。この酵素は、特願昭62−69598号に記載され
ている精製法によつて純品のものが得られる。こ
の純品の酵素はもちろん使用することができる
が、硫安分画あるいはDEAE−セフアロースクロ
マトグラフイーで得られる半精製品も使うことが
できる。このような酵素を用いて光学活性なアル
コールを製造するにあたり、例えば精製酵素0.01
〜200mgをPH5.5〜8.0、好ましくはPH6.5〜7.5の
0.1Mリン酸緩衝液1mlにとかし、原料のケトン
化合物(例えば4−クロロアセト酢酸エチル、2
−オクタノン、メチルイソブチルケトンなど)お
よび原料と等モルの還元型ニコチンアミドアデニ
ンジヌクレオチド(NADH)を添加する。この
反応では、添加したNADHは酸化されてニコチ
ンアミドアデニンジヌクレオチド(NAD)にな
るため、生産物と等モルのNADHを加える必要
がある。しかし、高価なNADHを有効に利用す
るためには、NADをNADHにするような酵素、
例えばグルコース脱水素酵素(以下GDHと略す、
アマノ製薬社製)や耐熱性のグルコース−6−リ
ン酸脱水素酵素(ユニチカ社製)、蟻酸脱水素酵
素(天野製薬社、ベーリンガー社、メルク社製な
ど)、あるいは3α−HSDH(KE3株由来精製酵素
やシグマ社製)などを共存させれば原料の1/10〜
1/10000モルのNAD(H)を添加するだけで反応
させることもできる。ケトン化合物の添加量は、
その種類によつて異なるが、酵素重量の約10〜
1000倍である。これらを加えて、15〜40℃、好ま
しくは25〜35℃で1時間から1週間攪拌しながら
反応を行う。反応液にアエロゾルOTやツイーン
80などの界面活性剤を添加した場合、より効率良
く反応させることができる。またDEAE−セフア
ロースやデユオライトA561のようなイオン交換
樹脂を反応系に加えることによつて、反応速度を
向上させたり酵素を安定に保ちながら反応を続け
ることもできる。反応の経時変化をガスクロマト
グラフイー(PEG2キヤピラリーカラム、25m、
50→150℃、10℃/minで昇温分析)で追跡し、
原料がほぼ失くなつた時点で反応を止め、遠心分
離することによつて、水層を分け生成物を採取す
る。回収率を高めるためには水中に溶けている生
産物を酢酸エチル、ヘキサン、ジエチルエーテ
ル、1,2−ジクロロエタン、クロロホルムなど
の溶媒を用いて抽出する。精製品が必要であれ
ば、これらの生産物を蒸留等によつて精製し、目
的の光学活性なアルコールを得ることができる。 The 3α-hydroxysteroid dehydrogenase (hereinafter abbreviated as 3α-HSDH) used in the present invention is Cellulomonas tourbata strain KE31
No.] is preferred, but is not limited thereto. This enzyme can be obtained in pure form by the purification method described in Japanese Patent Application No. 62-69598. Of course, this pure enzyme can be used, but semi-purified products obtained by ammonium sulfate fractionation or DEAE-Sepharose chromatography can also be used. When producing optically active alcohol using such an enzyme, for example, 0.01
~200mg PH5.5~8.0, preferably PH6.5~7.5
Dissolve in 1 ml of 0.1M phosphate buffer and add the starting ketone compound (e.g. ethyl 4-chloroacetoacetate, 2
-octanone, methyl isobutyl ketone, etc.) and reduced nicotinamide adenine dinucleotide (NADH) in an equimolar amount to the raw material. In this reaction, the added NADH is oxidized to nicotinamide adenine dinucleotide (NAD), so it is necessary to add an equimolar amount of NADH to the product. However, in order to effectively utilize expensive NADH, enzymes that convert NAD to NADH,
For example, glucose dehydrogenase (hereinafter abbreviated as GDH)
Amano Pharmaceutical Co., Ltd.), heat-stable glucose-6-phosphate dehydrogenase (Unitika Co., Ltd.), formate dehydrogenase (Amano Pharmaceutical Co., Ltd., Boehringer Co., Ltd., Merck Co., Ltd., etc.), or 3α-HSDH (derived from KE3 strain). If purified enzymes (manufactured by Sigma), etc. coexist, the amount will be 1/10 of the raw material.
The reaction can also be carried out simply by adding 1/10000 mole of NAD(H). The amount of ketone compound added is
It varies depending on the type, but about 10 to 10% of the enzyme weight
It is 1000 times more. These are added and the reaction is carried out at 15-40°C, preferably 25-35°C, with stirring for 1 hour to 1 week. Aerosol OT or Tween in the reaction solution
When a surfactant such as 80 is added, the reaction can be made more efficient. Furthermore, by adding an ion exchange resin such as DEAE-Sepharose or Duolite A561 to the reaction system, the reaction rate can be increased or the reaction can be continued while keeping the enzyme stable. Gas chromatography (PEG2 capillary column, 25 m,
50 → 150℃, temperature increase analysis at 10℃/min)
The reaction is stopped when almost all of the raw material is consumed, and the aqueous layer is separated by centrifugation and the product is collected. To increase the recovery rate, the product dissolved in water is extracted using a solvent such as ethyl acetate, hexane, diethyl ether, 1,2-dichloroethane, or chloroform. If a purified product is required, these products can be purified by distillation or the like to obtain the desired optically active alcohol.
実施例 1
光学活性4−クロロ−3(S)−ヒドロキシブタ
ン酸エチルの製法
0.2MNaclを含む0.1Mリン酸緩衝液(PH7.0)
18mlに1.5g(8.33ミリモル)のグルコース、7
mgの3α−HSDH(KE31株由来の精製酵素、
20U/mg蛋白)、NADH再生用酵素として2.5mgの
GDH(40U/mg蛋白)および191mg(0.25ミリモ
ル)のNADHを溶かし、これに1.2g(7.29ミリ
モル)の4−クロロアセト酢酸エチルを添加して
良く攪拌しながら20℃で反応した。反応が進むに
つれてPHが低下するので、1MのNa2CO3でPHを
7.0に調整し反応を続けた。3.5時間反応後、反応
液に酢酸エチル(20ml/2回)を加えて生成物を
抽出した。抽出液にNa2SO4を入れて水分を除去
した後、さらにモルキユラーシーブを加えて乾燥
した。標品に混在する酢酸エチルを減圧下で除去
し、750mg(4.5ミリモル)の4−クロロ−3−ヒ
ドロキシブタン酸エチルを得た。これを3,5−
ジニトロフエニルイソシアネート(以下DNPIと
略す)で誘導体化したあと液体クロマトグラフイ
ー(カラム:OA−2100、住友化学製、溶媒:ヘ
キサン/クロロホルム/エタノール=50/15/
1、流速1ml/min)によつて分析した。上述の
酵素反応によつて生成した3−ヒドロキシン体中
には99.1%の4−クロロ−3(S)−ヒドロキシブ
タン酸エチルと0.9%の4−クロロ−3(R)−ヒ
ドロキシブタン酸エチルが含まれており、3(S)
−ヒドロキシ体が優先的に生成した。4−クロロ
−3(S)−ヒドロキシブタン酸エチルの収率は62
%であつた。
Example 1 Method for producing optically active ethyl 4-chloro-3(S)-hydroxybutanoate 0.1M phosphate buffer containing 0.2M Nacl (PH7.0)
1.5 g (8.33 mmol) glucose in 18 ml, 7
mg of 3α-HSDH (purified enzyme derived from strain KE31,
20U/mg protein), 2.5mg as NADH regenerating enzyme
GDH (40 U/mg protein) and 191 mg (0.25 mmol) of NADH were dissolved, and 1.2 g (7.29 mmol) of ethyl 4-chloroacetoacetate was added thereto, followed by reaction at 20° C. with thorough stirring. As the reaction progresses, the PH decreases, so adjust the PH with 1M Na2CO3 .
I adjusted it to 7.0 and continued the reaction. After reacting for 3.5 hours, ethyl acetate (20 ml/twice) was added to the reaction solution to extract the product. After adding Na 2 SO 4 to the extract to remove moisture, a molecular sieve was further added for drying. Ethyl acetate present in the sample was removed under reduced pressure to obtain 750 mg (4.5 mmol) of ethyl 4-chloro-3-hydroxybutanoate. This is 3,5-
After derivatization with dinitrophenyl isocyanate (hereinafter abbreviated as DNPI), liquid chromatography (column: OA-2100, manufactured by Sumitomo Chemical, solvent: hexane/chloroform/ethanol = 50/15/
1, flow rate 1 ml/min). The 3-hydroxyne produced by the above enzymatic reaction contains 99.1% ethyl 4-chloro-3(S)-hydroxybutanoate and 0.9% ethyl 4-chloro-3(R)-hydroxybutanoate. Includes 3(S)
-Hydroxy form was preferentially produced. The yield of ethyl 4-chloro-3(S)-hydroxybutanoate is 62
It was %.
実施例 2
光学活性4−クロロ−3(S)−ヒドロキシブタ
ン酸エチルの製法
NADH再生用酵素として3α−HSDH(実施例
1と同様の精製酵素)、NADH再生用基質として
メチルイソブチルカルビノールを用いた。25μ
の0.1Mリン酸緩衝液(PH7.0)に2.33mgの3α−
HSDHおよび25μの5mM NADH(0.125μモ
ル)を加えて溶解し、260μメチルイソブチル
カルビノールおよび40μ(295μモル)の4−ク
ロロアセト酢酸エチルを加えて攪拌しながら30℃
で反応した。反応開始後66時間目に40μの4−
クロロアセト酢酸エチル、21時間目には40μの
4−クロロアセト酢酸エチルおよび260μのメ
チルイソブチルカルビノール、10μのリン酸緩
衝液を加えて、さらに60時間反応を続けた(総反
応時間は81時間)。反応終了後、ガスクロマトグ
ラフで分析した結果、810μモルの3−ヒドロキ
シ体が生成していた。この溶液に混在するメチル
イソブチルカルビノール、メチルイソブチルケト
ンを減圧下40℃で除去したあと、施光度の測定及
び液体クロマトグラフによつて異性体純度の測定
を行つた。クロロホルムに溶かした場合の比旋光
度は[α]25 589=−20.63degであり4−クロロ−3
(S)−ヒドロキシブタン酸エチルが優先的に生成
していた。またDNPIで誘導体化した標品を液体
クロマトグラフで分析した結果、99%の4−クロ
ロ−33(S)−ヒドロキシブタン酸エチルと1%の
4−クロロ−3(R)−ヒドロキシブタン酸エチル
が生成していた。4−クロロ−3(S)−ヒドロキ
シブタン酸エチルの収率は91%であつた。Example 2 Method for producing optically active ethyl 4-chloro-3(S)-hydroxybutanoate 3α-HSDH (purified enzyme similar to Example 1) was used as the enzyme for regenerating NADH, and methylisobutylcarbinol was used as the substrate for regenerating NADH. there was. 25μ
2.33 mg 3α− in 0.1 M phosphate buffer (PH7.0)
Add and dissolve HSDH and 25μ of 5mM NADH (0.125μmol), add 260μ methylisobutylcarbinol and 40μ (295μmol) of ethyl 4-chloroacetoacetate and incubate at 30°C with stirring.
I reacted. 66 hours after the start of the reaction, 40μ of 4-
Ethyl chloroacetoacetate, 40μ of ethyl 4-chloroacetoacetate, 260μ of methylisobutyl carbinol, and 10μ of phosphate buffer were added at 21 hours, and the reaction was continued for an additional 60 hours (total reaction time 81 hours). After the reaction was completed, analysis by gas chromatography revealed that 810 μmol of 3-hydroxy compound had been produced. After removing methyl isobutyl carbinol and methyl isobutyl ketone mixed in this solution at 40° C. under reduced pressure, the isomer purity was measured by measuring the degree of light exposure and liquid chromatography. The specific optical rotation when dissolved in chloroform is [α] 25 589 = -20.63deg, which is 4-chloro-3
Ethyl (S)-hydroxybutanoate was preferentially produced. In addition, as a result of liquid chromatography analysis of the sample derivatized with DNPI, 99% of ethyl 4-chloro-33(S)-hydroxybutanoate and 1% of ethyl 4-chloro-3(R)-hydroxybutanoate were found. was being generated. The yield of ethyl 4-chloro-3(S)-hydroxybutanoate was 91%.
実施例 3
光学活性4−クロロ−3(S)−ヒドロキシブタ
ン酸エチルの製法
酵素の反応速度および安定性を高めるために70
mgの膨潤状態のDEAE−セフアロースを添加し
て、実施例2と同様にして反応を行なつた。反応
終了液をガスクロ分析したところ860μモルの3
−ヒドロキシ体が生成していた。またメチルイソ
ブチルカルビノール、メチルイソブチルケトンを
除去したあと、旋光度の測定および液体クロマト
グラフによつて異性体純度の測定を行つた。クロ
ロホルム中におけ比旋光度は[α]25 589=−
20.71degであり4−クロロ−3(S)−ヒドロキシ
ブタン酸エチルが優先的に生成していた。また
DNPI誘導体を液体クロマトグラフで分析した結
果、99.2%の4−クロロ−3(S)−ヒドロキシブ
タン酸エチルと0.8%の4−クロロ−3(R)−ヒ
ドロキシブタン酸エチルが生成していた。4−ク
ロロ−3(S)−ヒドロキシブタン酸エチルの収率
は97%であつた。Example 3 Method for producing optically active ethyl 4-chloro-3(S)-hydroxybutanoate In order to increase the reaction rate and stability of the enzyme, 70
A reaction was carried out in the same manner as in Example 2 by adding mg of swollen DEAE-Sepharose. Gas chromatography analysis of the reaction completed solution revealed 860 μmol of 3
-Hydroxy forms were produced. After removing methyl isobutyl carbinol and methyl isobutyl ketone, the isomer purity was measured by optical rotation and liquid chromatography. The specific rotation in chloroform is [α] 25 589 =-
20.71 degrees, and ethyl 4-chloro-3(S)-hydroxybutanoate was preferentially produced. Also
Analysis of the DNPI derivative by liquid chromatography revealed that 99.2% of ethyl 4-chloro-3(S)-hydroxybutanoate and 0.8% of ethyl 4-chloro-3(R)-hydroxybutanoate were produced. The yield of ethyl 4-chloro-3(S)-hydroxybutanoate was 97%.
実施例 4
光学活性R−(−)−2−オクタールの製法
0.2M NaClを含む0.1Mリン酸緩衝液(PH7.0)
1mlに0.51g(2.83ミリモル)のグルコース、1
mgの3α−HSDH(KE31株由来の精製酵素、2.6mg
のGDHおよび10mgのNADH(13μモル)を溶か
し、これに0.1ml(82mg、640μモル)の2−オク
タノンを添加して2℃で反応を行つた。反応と共
にPHは低下するので絶えずスターラーで攪拌し、
1MのNa2CO3でPH7.0に調整しながら反応させた。
15時間反応後(途中6時間目に1mgのGDHおよ
び6mgのNADHをさらに添加した)、反応液に
1,2−ジクロロエタン(1.5mm×2回)を加え
て生産物を抽出した。遠心分離後1,2−ジクロ
ロエタン層(油層)回収し、ガスクロマトグラフ
を用いて分析した。油層中には64mg(490μモル)
の2−オクタノールが生成していた。この標品の
旋光度を測定したところ、比旋光度[α]25 589=−
6.7degであり、R体が優先的に生成していた。一
方、純品のR−(−)−2−オクタノールの比旋光
度は[α]25 589=−9.745degであつた。次に前述の
油層に1.6gのNa2SO4を加えて1夜、攪拌したの
ち0.3ml採取してモルキユラシーブを入れてさら
に1夜放置した。この液に33mgのDNPIを加えて
よく攪拌し、さらに30μの乾燥ピリジンを加え
て攪拌したのち4時間放置した。この誘導体を液
体クロマトグラフイーで分析したところ、生成し
た2−オクタノールのうち84.5%はR−(−)−2
−オクタノールであり、15.5%はS−(+)−2−
オクタノールであつた。R−(−)−2−オクタノ
ールの収率は67%であつた。Example 4 Production method of optically active R-(-)-2-octal 0.1M phosphate buffer containing 0.2M NaCl (PH7.0)
0.51 g (2.83 mmol) glucose per 1 ml, 1
mg of 3α-HSDH (purified enzyme from KE31 strain, 2.6 mg
of GDH and 10 mg of NADH (13 μmol) were dissolved, 0.1 ml (82 mg, 640 μmol) of 2-octanone was added thereto, and the reaction was carried out at 2°C. As the pH decreases with the reaction, constantly stir with a stirrer.
The reaction was carried out while adjusting the pH to 7.0 with 1M Na 2 CO 3 .
After 15 hours of reaction (1 mg of GDH and 6 mg of NADH were further added at 6 hours), 1,2-dichloroethane (1.5 mm x 2) was added to the reaction solution to extract the product. After centrifugation, the 1,2-dichloroethane layer (oil layer) was collected and analyzed using a gas chromatograph. 64mg (490μmol) in oil layer
2-octanol was produced. When the optical rotation of this sample was measured, the specific rotation [α] 25 589 = -
It was 6.7 degrees, and the R form was preferentially produced. On the other hand, the specific optical rotation of pure R-(-)-2-octanol was [α] 25 589 =-9.745 degrees. Next, 1.6 g of Na 2 SO 4 was added to the above-mentioned oil layer, and the mixture was stirred overnight, and then 0.3 ml was collected, and molecuura sieve was added thereto, and the mixture was left to stand for another night. To this solution, 33 mg of DNPI was added and stirred thoroughly, and 30 μm of dry pyridine was further added and stirred, and then left for 4 hours. When this derivative was analyzed by liquid chromatography, 84.5% of the 2-octanol produced was R-(-)-2.
-octanol and 15.5% is S-(+)-2-
It was hot with octanol. The yield of R-(-)-2-octanol was 67%.
実施例 5
光学活性2−メチル−4(S)−ヒドロキシペン
タンの製法
0.1M NaClを含む0.1Mリン酸緩衝液(PH7.0)
2.8mlに1.99g(11.1ミリモル)のグルコース、
2.6mgの3α−HSDH(K31E株由来精製酵素)、2.7
mgのGDHおよび20mgのNADH(26μモル)を溶か
し、これに0.6ml480mg、4.97ミリモル)のメチル
イソブチルケトンを添加してPH7.0に調整しなが
ら25℃で反応を行なつた。15時間反応後(途中6
時間目に2mgのGDHおよび12mgのNADHをさら
に添加した)、反応液に1,2−ジクロロエタン
(2.5ml×2回)を加えて抽出し、遠心分離して
1,2−ジクロロエタン層(油層)を回収した。
これをガスクロマトグラフで分析したところ215
mgのメチルイソブチルカルビノールが生成してい
た。この標品の旋光度を測定したところ、比旋光
度[α]25 589=+0.127degであつた。またDNPIで
誘導体化した後、液体クロマトグラフによつて、
異性体の純度を測定した結果、2−メチル−4
(S)−ヒドロキシペンタンは62.4%、2−メチル
−4(R)−ヒドロキシペンタンは37.6%含まれて
おり、4(S)−ヒドロキシ体が優先的に生成して
いた。2−メチル−4(S)−ヒドロキシペンタン
の収率は27.8%であつた。Example 5 Method for producing optically active 2-methyl-4(S)-hydroxypentane 0.1M phosphate buffer containing 0.1M NaCl (PH7.0)
1.99 g (11.1 mmol) glucose in 2.8 ml,
2.6 mg of 3α-HSDH (purified enzyme derived from strain K31E), 2.7
mg of GDH and 20 mg of NADH (26 μmol) were dissolved, and 0.6 ml (480 mg, 4.97 mmol) of methyl isobutyl ketone was added thereto, and the reaction was carried out at 25° C. while adjusting the pH to 7.0. After 15 hours of reaction (in the middle of 6
2 mg of GDH and 12 mg of NADH were further added to the reaction mixture), 1,2-dichloroethane (2.5 ml x 2) was added to the reaction solution for extraction, and the mixture was centrifuged to form a 1,2-dichloroethane layer (oil layer). was recovered.
When this was analyzed using a gas chromatograph, 215
mg of methylisobutylcarbinol was produced. When the optical rotation of this sample was measured, it was found to be specific optical rotation [α] 25 589 = +0.127 deg. In addition, after derivatization with DNPI, by liquid chromatography,
As a result of measuring the purity of the isomer, 2-methyl-4
It contained 62.4% (S)-hydroxypentane and 37.6% 2-methyl-4(R)-hydroxypentane, and the 4(S)-hydroxy form was preferentially produced. The yield of 2-methyl-4(S)-hydroxypentane was 27.8%.
本発明方法によれば、副産物が少なく効よく、
光学活性アルコールを製造することができる。
According to the method of the present invention, there are few by-products and the method is effective.
Optically active alcohols can be produced.
Claims (1)
いて、一般式〔1〕 (式中、R1はメチル基又はハロゲン置換メチル
基を、R2は炭素数1〜5のアルキル基を示す)、 または、一般式〔2〕 (式中、nは1〜10の整数を示す) で示されるケトン化合物を光学活性アルコールに
変換することを特徴とする光学活性アルコールの
製造方法。 2 3α−ヒドロキシステロイド脱水素酵素がセ
ルロモナス属由来の酵素である請求項1記載の製
造方法。[Claims] Using 13α-hydroxysteroid dehydrogenase, the general formula [1] (In the formula, R 1 represents a methyl group or a halogen-substituted methyl group, and R 2 represents an alkyl group having 1 to 5 carbon atoms), or general formula [2] (In the formula, n represents an integer of 1 to 10.) A method for producing an optically active alcohol, which comprises converting a ketone compound represented by the following into an optically active alcohol. 2. The production method according to claim 1, wherein the 23α-hydroxysteroid dehydrogenase is an enzyme derived from the genus Cellulomonas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63103851A JPH01277494A (en) | 1988-04-28 | 1988-04-28 | Production of optical active alcohol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63103851A JPH01277494A (en) | 1988-04-28 | 1988-04-28 | Production of optical active alcohol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01277494A JPH01277494A (en) | 1989-11-07 |
| JPH045436B2 true JPH045436B2 (en) | 1992-01-31 |
Family
ID=14364944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63103851A Granted JPH01277494A (en) | 1988-04-28 | 1988-04-28 | Production of optical active alcohol |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01277494A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3155107B2 (en) * | 1993-01-12 | 2001-04-09 | ダイセル化学工業株式会社 | Method for producing optically active 4-halo-3-hydroxybutyrate |
| JP4012299B2 (en) | 1998-02-25 | 2007-11-21 | ダイセル化学工業株式会社 | Method for producing optically active alcohol containing halogen substitution |
| TWI275645B (en) * | 2000-02-16 | 2007-03-11 | Daicel Chemical Industries Ltd. | (R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes |
-
1988
- 1988-04-28 JP JP63103851A patent/JPH01277494A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01277494A (en) | 1989-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0753116B2 (en) | Enzymatic method for producing optically active cyanohydrin | |
| JPS63284184A (en) | Optically active compound and production thereof | |
| US5457051A (en) | Enantioselective hydrolysis of ketoprofen esters by beauveria bassiana and enzymes derived therefrom | |
| JPH045436B2 (en) | ||
| JP2578658B2 (en) | Optically active compound and method for producing the same | |
| JP2698627B2 (en) | Method for producing optically active amines and derivatives thereof | |
| JP3705046B2 (en) | Preparation of optically active 4-halogeno-1,3-butanediol and its derivatives by microorganisms | |
| JPH01132399A (en) | Production of optically active unsaturated alcohol and esterified product thereof | |
| JP2981250B2 (en) | Method for producing D-pantothenonitrile | |
| JP3217301B2 (en) | Method for producing optically active glycidic acid ester and optically active glyceric acid ester | |
| JP3183763B2 (en) | Method for producing optically active 1-benzyloxy-2-alkanol | |
| JP3010382B2 (en) | Method for producing (R) -2-propoxybenzene derivative | |
| JPS6332492A (en) | Production of levorotatory optically active isomer of mandelic acid by enzymatic process | |
| JP3183756B2 (en) | Method for producing optically active 1-benzyloxy-2-alkanol | |
| JP3007461B2 (en) | Method for producing optically active 2-cyclohexenylacetic acid and its ester | |
| JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
| JP3107244B2 (en) | Method for producing optically active diol | |
| JPH047678B2 (en) | ||
| JP3192835B2 (en) | Method for producing (S) -1,3-butanediol | |
| JPS6012993A (en) | Method for producing optically active carboxylic acid | |
| JP2001169798A (en) | Method for producing both enantiomers of optically active azulene trifluoroethanol derivative using lipase | |
| JP2716477B2 (en) | Method for producing S-carboxymethyl-L-cysteine | |
| JPH0574349B2 (en) | ||
| KR100446256B1 (en) | Process for preparing cis-2-(bromomethyl)-2-(2,4-dichlorophenyl)-13-dioxolane-4-methyl alcohol of high optical selectivity | |
| JPH0632633B2 (en) | Process for producing optically active carboxylic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |